Abstract:Description: The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update is to review the available evidence and best practice advice statements regarding the use of endoscopic therapies in treating patients with non-variceal upper gastrointestinal bleeding. Methods: This expert review was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. This review is framed around the 10 best practice advice points agreed upon by the authors, which reflect landmark and recent published articles in this field. This expert review also reflects the experiences of the authors who are gastroenterologists with extensive experience in managing and teaching others to treat patients with non-variceal upper gastrointestinal bleeding (NVUGIB). BEST PRACTICE ADVICE 1: Endoscopic therapy should achieve hemostasis in the majority of patients with NVUGIB. BEST PRACTICE ADVICE 2: Initial management of the patient with NVUGIB should focus on resuscitation, triage, and preparation for upper endoscopy. After stabilization, patients with NVUGIB should undergo endoscopy with endoscopic treatment of sites with active bleeding or high-risk stigmata for rebleeding. BEST PRACTICE ADVICE 3: Endoscopists should be familiar with the indications, efficacy, and limitations of currently available tools and techniques for endoscopic hemostasis, and be comfortable applying conventional thermal therapy and placing hemoclips. BEST PRACTICE ADVICE 4: Monopolar hemostatic forceps with low-voltage coagulation can be an effective alternative to other mechanical and thermal treatments for NVUGIB, particularly for ulcers in difficult locations or those with a rigid and fibrotic base. BEST PRACTICE ADVICE 5: Hemostasis using an over-the-scope clip should be considered in select patients with NVUGIB, in whom conventional electrosurgical coagulation and hemostatic clips are unsuccessful or predicted to be ineffective. BEST PRACTICE ADVICE 6: Hemostatic powders are a noncontact endoscopic option that may be considered in cases of massive bleeding with poor visualization, for salvage therapy, and for diffuse bleeding from malignancy. BEST PRACTICE ADVICE 7: Hemostatic powder should be preferentially used as a rescue therapy and not for primary hemostasis, except in cases of malignant bleeding or massive bleeding with inability to perform thermal therapy or hemoclip placement. BEST PRACTICE ADVICE 8: Endoscopists should understand the risk of bleeding from therapeutic endoscopic interventions (eg, endoluminal resection and endoscopic sphincterotomy) and be familiar with the endoscopic tools and techniques to treat intraprocedural bleeding and minimize the risk of delayed bleeding. BEST PRACTICE ADVICE 9: In patients with endoscopically refractory NVUGIB, the etiology of bleeding (peptic ulcer disease, unknown source, post surgical); patient factors (hemodynamic instability, coagulopathy, multi-organ failure, surgical history); risk of rebleeding; and potential adverse events should be taken into consideration when deciding on a case-by-case basis between transcatheter arterial embolization and surgery. BEST PRACTICE ADVICE 10: Prophylactic transcatheter arterial embolization of high-risk ulcers after successful endoscopic therapy is not encouraged.

Achievement of endoscopic hemostasis

Peptic Ulcers: Achievement of endoscopic hemostasis

Recent Developments in the Endoscopic Treatment of Patients with Peptic Ulcer Bleeding

Treatment of upper gastrointestinal bleeding in 2020: New techniques and outcomes

Endoscopic hemostasis for peptic ulcer bleeding: systematic review and meta-analyses of randomized controlled trials

Turn over the new leaf of the treatment in peptic ulcer bleeding: a review of the literature

Advancements in endoscopic hemostasis for non-variceal upper gastrointestinal bleeding

Peptic Ulcer Bleeding: Update on Standards from International Guidelines

157 Early Angiographic Embolization after Endoscopic Hemostasis to High Risk Bleeding Peptic Ulcers Improves Outcomes

Challenges in the Management of Acute Peptic Ulcer Bleeding

Clinical value of endoscopic treatment for bleeding peptic ulcer

Endoscopic Hemostasis for Non-Variceal Upper Gastrointestinal Bleeding: New Frontiers

S1575: Nanopowders Are Highly Effective in Achieving Hemostasis in Severe Peptic Ulcer Bleeding: an Interim Report of a Prospective Human Trial

Marshall and Warren Lecture 2009: peptic ulcer bleeding: an expedition of 20 years from 1989-2009

Recent advances in the management of peptic ulcer bleeding

[Endoscopic Management of Early Postoperative Anastomotic Hemorrhage].

AGA Clinical Practice Update on Endoscopic Therapies for Non-Variceal Upper Gastrointestinal Bleeding: Expert Review

Systematic review and meta‐analysis of endoscopic versus medical management of peptic ulcers with adherent clots

Endoscopic advances in the management of non-variceal upper gastrointestinal bleeding: A review

116 Early and Late Resumption of Aspirin after Endoscopic Therapy for Bleeding Peptic Ulcers - A Cohort Study

Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding